Next-generation Sequencing Library Preparation

Description

Global Next-generation Sequencing Library Preparation Market to Reach US$4.1 Billion by 2030

The global market for Next-generation Sequencing Library Preparation estimated at US$1.9 Billion in the year 2024, is expected to reach US$4.1 Billion by 2030, growing at a CAGR of 13.4% over the analysis period 2024-2030. Targeted Genome Sequencing, one of the segments analyzed in the report, is expected to record a 10.4% CAGR and reach US$1.4 Billion by the end of the analysis period. Growth in the Whole Genome Sequencing segment is estimated at 15.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$503.5 Million While China is Forecast to Grow at 12.8% CAGR

The Next-generation Sequencing Library Preparation market in the U.S. is estimated at US$503.5 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$638.2 Million by the year 2030 trailing a CAGR of 12.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 11.9% and 11.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 10.1% CAGR.

Global Next-Generation Sequencing Library Preparation Market - Key Trends & Drivers Summarized

How Is Next-Generation Sequencing Library Preparation Advancing Genomic Research?

Next-generation sequencing (NGS) library preparation is a critical step in genomic analysis, enabling researchers to convert DNA and RNA samples into formats suitable for high-throughput sequencing. The preparation process involves fragmentation, adapter ligation, amplification, and quality control, ensuring accurate and efficient sequencing. NGS technology has revolutionized genetics, allowing for faster and more cost-effective analysis of genomes, transcriptomes, and epigenomes across various applications, including precision medicine, oncology, infectious disease research, and agricultural genomics. The increasing adoption of NGS in clinical diagnostics is driving demand for more streamlined, automation-friendly, and scalable library preparation kits that enhance efficiency and reproducibility. Additionally, advancements in single-cell sequencing and long-read sequencing are pushing the boundaries of genome analysis, necessitating improved library preparation methods tailored for complex samples. As researchers strive for higher sequencing accuracy, sensitivity, and throughput, library preparation technologies continue to evolve, playing a crucial role in advancing the field of genomics.

What Challenges Are Affecting the Adoption of NGS Library Preparation Technologies?

Despite its transformative potential, the NGS library preparation market faces several challenges that impact accessibility, efficiency, and cost-effectiveness. One of the primary concerns is the labor-intensive nature of traditional library preparation methods, which require skilled technicians, expensive reagents, and extensive sample handling. Variability in sample quality and preparation efficiency can lead to sequencing errors and reduced data reliability, necessitating robust quality control measures. Another major challenge is the high cost of library preparation kits, which can be prohibitive for smaller research institutions and clinical laboratories. Additionally, the complexity of handling diverse sample types, including low-input and degraded DNA, requires highly specialized protocols, increasing the need for customized solutions. Regulatory challenges and standardization issues further hinder clinical adoption, as laboratories must adhere to stringent compliance requirements for NGS-based diagnostics. Overcoming these challenges will require continued innovation in automation, reagent chemistry, and bioinformatics solutions to make NGS library preparation more efficient, cost-effective, and scalable for a wider range of applications.

How Are Innovations Driving the Future of NGS Library Preparation?

Technological advancements are significantly improving the efficiency and accuracy of NGS library preparation, addressing key challenges in sample processing and sequencing quality. One of the most impactful innovations is the automation of library preparation workflows, reducing hands-on time, minimizing human error, and increasing sample throughput. Robotic liquid handling systems and microfluidic platforms are streamlining the preparation process, making high-throughput sequencing more accessible to clinical and research laboratories. The development of transposase-based library preparation methods, such as Illumina’s Nextera technology, is simplifying DNA fragmentation and adapter insertion, reducing preparation time and reagent costs. Additionally, single-tube and direct RNA sequencing approaches are eliminating the need for complex workflows, improving efficiency in transcriptomics studies. Advances in molecular barcoding and unique molecular identifiers (UMIs) are enhancing sequencing accuracy by reducing PCR bias and detecting low-frequency variants. The integration of AI and machine learning in bioinformatics is also optimizing library preparation protocols by predicting optimal reagent conditions and improving data interpretation. As these innovations continue to evolve, the NGS library preparation market is poised for greater efficiency, scalability, and clinical adoption.

What Is Driving the Growth of the NGS Library Preparation Market?

The growth in the next-generation sequencing library preparation market is driven by several factors, including increasing demand for personalized medicine, expanding applications of NGS in disease research, and technological advancements in automation and reagent chemistry. The growing adoption of NGS-based diagnostics in oncology, infectious diseases, and rare genetic disorders is fueling demand for more efficient and cost-effective library preparation solutions. The rise of single-cell sequencing is also contributing to market growth, as researchers require specialized library preparation methods to analyze individual cells with high sensitivity. Additionally, the expansion of agricultural genomics, microbiome studies, and synthetic biology is further driving market demand, as these fields rely on high-throughput sequencing for genomic analysis. The push for standardization and regulatory approvals for clinical NGS applications is also shaping market trends, with manufacturers developing compliant library preparation kits that meet stringent diagnostic requirements. Investments in bioinformatics and cloud-based sequencing platforms are enhancing data management and accessibility, making NGS more widely available for diverse research and clinical applications. As advancements in sequencing technologies continue to lower costs and improve accuracy, the NGS library preparation market is expected to witness sustained growth, revolutionizing genomic research and precision medicine.

SCOPE OF STUDY:

The report analyzes the Next-generation Sequencing Library Preparation market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Sequencing Type (Targeted Genome Sequencing, Whole Genome Sequencing, Whole Exome Sequencing, Other Sequencing Types); Product Type (Library Preparation Reagents & Consumables, Library Preparation Instruments); Application (Drug & Biomarker Discovery Application, Disease Diagnostics Application, Cancer Diagnostics Application, Reproductive Health Diagnostics Application, Infectious Disease Diagnostics Application, Other Disease Diagnostic Applications); End-Use (Academic & Research Institutions End-Use, Pharma & Biotech Companies End-Use, Hospitals & Clinics End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 48 Featured) -

Agilent Technologies, Inc.
Alida Biosciences, Inc.
Beckman Coulter, Inc.
Becton, Dickinson and Company (BD)
Bio-Rad Laboratories, Inc.
CD Genomics
Claret Bioscience LLC
F. Hoffmann-La Roche AG
Fluidigm Corporation
Hamilton Company
Illumina, Inc.
New England Biolabs Inc.
Oxford Nanopore Technologies Ltd.
Pacific Biosciences of California, Inc.
PerkinElmer, Inc.
QIAGEN N.V.
Swift Biosciences Inc.
Takara Bio Inc.
Tecan Group Ltd.
Thermo Fisher Scientific Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

Product Code: MCP32336

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
- Influencer Market Insights
- Tariff Impact on Global Supply Chain Patterns
- Next-generation Sequencing Library Preparation - Global Key Competitors Percentage Market Share in 2025 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
- Surge in Precision Medicine Initiatives Throws the Spotlight on Customized NGS Library Preparation Solutions
- Rapid Growth of Clinical Diagnostics Strengthens Business Case for Automation in Library Preparation Workflows
- Increasing Focus on Genomic Surveillance Accelerates Demand for High-Throughput NGS Library Prep Kits
- Rising Investments in Cancer Genomics Propels Growth of Targeted Sequencing Library Preparation Products
- Expansion of Population Genomics Programs Expands Addressable Market Opportunity for Large-Scale Library Prep Platforms
- Adoption of AI and Machine Learning in Genomic Data Analysis Spurs Demand for Standardized, High-Quality Library Prep Methods
- Growing Use of Liquid Biopsy Technologies Drives Adoption of Ultra-Sensitive Library Preparation Protocols
- Regulatory Push for Validated and Reproducible Clinical Assays Strengthens Business Case for Commercial NGS Library Kits
- Integration of Automation and Robotics in Lab Workflows Drives Efficiency and Reduces Human Error in Library Preparation
- Increasing Demand for Decentralized Testing Models Spurs Development of Point-of-Care Compatible Library Prep Technologies
- Rising Demand for Epigenetic and Transcriptomic Studies Expands Scope for Specialized Library Preparation Solutions
- Advancements in Long-Read Sequencing Technologies Drives Innovation in Compatible Library Preparation Reagents
- Continuous Decline in Sequencing Costs Sustains Growth Momentum Across Research and Clinical Applications
- Strategic Collaborations Between Pharma and Genomics Firms Fuel Adoption of Scalable NGS Library Preparation Platforms
- Expansion of Biobanking and Genomic Data Repositories Generates Long-Term Demand for Reliable Library Prep Protocols
- Transition to Cloud-Based Genomics Workflows Spurs Demand for Seamlessly Integratable Library Prep Solutions
- Emphasis on Quality Control and Standardization Across Labs Strengthens Need for Pre-Validated Library Prep Kits
- Accelerating Adoption of NGS in Agriculture and Microbiome Research Opens New Market Avenues for Library Preparation Products
- Government Funding Initiatives and Genomics-Focused National Programs Drive Regional Market Penetration and Adoption
- Intensifying Competitive Landscape Spurs Innovation in Fast, Cost-Effective, and Scalable Library Preparation Technologies
- Emergence of Single-Cell Sequencing Drives Demand for Ultra-Low Input and Specialized Library Prep Workflows
- Growing Importance of Data Privacy and Compliance Creates Challenges in Adoption of Cloud-Linked NGS Prep Systems
- Movement Toward Personalized Wellness and Preventive Healthcare Expands Market Opportunity for Consumer-Directed Library Prep Solutions
- Increasing Academia-Industry Collaborations Propels Development of Customizable and Niche Library Preparation Technologies
- Shift Toward Multiplexed and Multi-Omic Sequencing Accelerates Innovation in Versatile Library Prep Protocols
4. GLOBAL MARKET PERSPECTIVE
- TABLE 1: World Next-generation Sequencing Library Preparation Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
- TABLE 2: World Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 3: World 6-Year Perspective for Next-generation Sequencing Library Preparation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
- TABLE 4: World Recent Past, Current & Future Analysis for Targeted Genome Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 5: World 6-Year Perspective for Targeted Genome Sequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
- TABLE 6: World Recent Past, Current & Future Analysis for Whole Genome Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 7: World 6-Year Perspective for Whole Genome Sequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
- TABLE 8: World Recent Past, Current & Future Analysis for Whole Exome Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 9: World 6-Year Perspective for Whole Exome Sequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
- TABLE 10: World Recent Past, Current & Future Analysis for Other Sequencing Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 11: World 6-Year Perspective for Other Sequencing Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
- TABLE 12: World Recent Past, Current & Future Analysis for Reproductive Health Diagnostics Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 13: World 6-Year Perspective for Reproductive Health Diagnostics Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
- TABLE 14: World Recent Past, Current & Future Analysis for Infectious Disease Diagnostics Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 15: World 6-Year Perspective for Infectious Disease Diagnostics Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
- TABLE 16: World Recent Past, Current & Future Analysis for Other Disease Diagnostic Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 17: World 6-Year Perspective for Other Disease Diagnostic Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
- TABLE 18: World Recent Past, Current & Future Analysis for Drug & Biomarker Discovery Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 19: World 6-Year Perspective for Drug & Biomarker Discovery Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
- TABLE 20: World Recent Past, Current & Future Analysis for Disease Diagnostics Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 21: World 6-Year Perspective for Disease Diagnostics Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
- TABLE 22: World Recent Past, Current & Future Analysis for Cancer Diagnostics Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 23: World 6-Year Perspective for Cancer Diagnostics Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
- TABLE 24: World Recent Past, Current & Future Analysis for Academic & Research Institutions End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 25: World 6-Year Perspective for Academic & Research Institutions End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
- TABLE 26: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 27: World 6-Year Perspective for Pharma & Biotech Companies End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
- TABLE 28: World Recent Past, Current & Future Analysis for Hospitals & Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 29: World 6-Year Perspective for Hospitals & Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
- TABLE 30: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 31: World 6-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
- TABLE 32: World Recent Past, Current & Future Analysis for Library Preparation Reagents & Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 33: World 6-Year Perspective for Library Preparation Reagents & Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
- TABLE 34: World Recent Past, Current & Future Analysis for Library Preparation Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 35: World 6-Year Perspective for Library Preparation Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

UNITED STATES
- Next-generation Sequencing Library Preparation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
- TABLE 36: USA Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Sequencing Type - Targeted Genome Sequencing, Whole Genome Sequencing, Whole Exome Sequencing and Other Sequencing Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 37: USA 6-Year Perspective for Next-generation Sequencing Library Preparation by Sequencing Type - Percentage Breakdown of Value Sales for Targeted Genome Sequencing, Whole Genome Sequencing, Whole Exome Sequencing and Other Sequencing Types for the Years 2025 & 2030
- TABLE 38: USA Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Application - Reproductive Health Diagnostics Application, Infectious Disease Diagnostics Application, Other Disease Diagnostic Applications, Drug & Biomarker Discovery Application, Disease Diagnostics Application and Cancer Diagnostics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 39: USA 6-Year Perspective for Next-generation Sequencing Library Preparation by Application - Percentage Breakdown of Value Sales for Reproductive Health Diagnostics Application, Infectious Disease Diagnostics Application, Other Disease Diagnostic Applications, Drug & Biomarker Discovery Application, Disease Diagnostics Application and Cancer Diagnostics Application for the Years 2025 & 2030
- TABLE 40: USA Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by End-Use - Academic & Research Institutions End-Use, Pharma & Biotech Companies End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 41: USA 6-Year Perspective for Next-generation Sequencing Library Preparation by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutions End-Use, Pharma & Biotech Companies End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2025 & 2030
- TABLE 42: USA Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Product Type - Library Preparation Reagents & Consumables and Library Preparation Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 43: USA 6-Year Perspective for Next-generation Sequencing Library Preparation by Product Type - Percentage Breakdown of Value Sales for Library Preparation Reagents & Consumables and Library Preparation Instruments for the Years 2025 & 2030
CANADA
- TABLE 44: Canada Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Sequencing Type - Targeted Genome Sequencing, Whole Genome Sequencing, Whole Exome Sequencing and Other Sequencing Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 45: Canada 6-Year Perspective for Next-generation Sequencing Library Preparation by Sequencing Type - Percentage Breakdown of Value Sales for Targeted Genome Sequencing, Whole Genome Sequencing, Whole Exome Sequencing and Other Sequencing Types for the Years 2025 & 2030
- TABLE 46: Canada Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Application - Reproductive Health Diagnostics Application, Infectious Disease Diagnostics Application, Other Disease Diagnostic Applications, Drug & Biomarker Discovery Application, Disease Diagnostics Application and Cancer Diagnostics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 47: Canada 6-Year Perspective for Next-generation Sequencing Library Preparation by Application - Percentage Breakdown of Value Sales for Reproductive Health Diagnostics Application, Infectious Disease Diagnostics Application, Other Disease Diagnostic Applications, Drug & Biomarker Discovery Application, Disease Diagnostics Application and Cancer Diagnostics Application for the Years 2025 & 2030
- TABLE 48: Canada Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by End-Use - Academic & Research Institutions End-Use, Pharma & Biotech Companies End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 49: Canada 6-Year Perspective for Next-generation Sequencing Library Preparation by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutions End-Use, Pharma & Biotech Companies End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2025 & 2030
- TABLE 50: Canada Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Product Type - Library Preparation Reagents & Consumables and Library Preparation Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 51: Canada 6-Year Perspective for Next-generation Sequencing Library Preparation by Product Type - Percentage Breakdown of Value Sales for Library Preparation Reagents & Consumables and Library Preparation Instruments for the Years 2025 & 2030
JAPAN
- Next-generation Sequencing Library Preparation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
- TABLE 52: Japan Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Sequencing Type - Targeted Genome Sequencing, Whole Genome Sequencing, Whole Exome Sequencing and Other Sequencing Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 53: Japan 6-Year Perspective for Next-generation Sequencing Library Preparation by Sequencing Type - Percentage Breakdown of Value Sales for Targeted Genome Sequencing, Whole Genome Sequencing, Whole Exome Sequencing and Other Sequencing Types for the Years 2025 & 2030
- TABLE 54: Japan Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Application - Reproductive Health Diagnostics Application, Infectious Disease Diagnostics Application, Other Disease Diagnostic Applications, Drug & Biomarker Discovery Application, Disease Diagnostics Application and Cancer Diagnostics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 55: Japan 6-Year Perspective for Next-generation Sequencing Library Preparation by Application - Percentage Breakdown of Value Sales for Reproductive Health Diagnostics Application, Infectious Disease Diagnostics Application, Other Disease Diagnostic Applications, Drug & Biomarker Discovery Application, Disease Diagnostics Application and Cancer Diagnostics Application for the Years 2025 & 2030
- TABLE 56: Japan Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by End-Use - Academic & Research Institutions End-Use, Pharma & Biotech Companies End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 57: Japan 6-Year Perspective for Next-generation Sequencing Library Preparation by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutions End-Use, Pharma & Biotech Companies End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2025 & 2030
- TABLE 58: Japan Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Product Type - Library Preparation Reagents & Consumables and Library Preparation Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 59: Japan 6-Year Perspective for Next-generation Sequencing Library Preparation by Product Type - Percentage Breakdown of Value Sales for Library Preparation Reagents & Consumables and Library Preparation Instruments for the Years 2025 & 2030
CHINA
- Next-generation Sequencing Library Preparation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
- TABLE 60: China Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Sequencing Type - Targeted Genome Sequencing, Whole Genome Sequencing, Whole Exome Sequencing and Other Sequencing Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 61: China 6-Year Perspective for Next-generation Sequencing Library Preparation by Sequencing Type - Percentage Breakdown of Value Sales for Targeted Genome Sequencing, Whole Genome Sequencing, Whole Exome Sequencing and Other Sequencing Types for the Years 2025 & 2030
- TABLE 62: China Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Application - Reproductive Health Diagnostics Application, Infectious Disease Diagnostics Application, Other Disease Diagnostic Applications, Drug & Biomarker Discovery Application, Disease Diagnostics Application and Cancer Diagnostics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 63: China 6-Year Perspective for Next-generation Sequencing Library Preparation by Application - Percentage Breakdown of Value Sales for Reproductive Health Diagnostics Application, Infectious Disease Diagnostics Application, Other Disease Diagnostic Applications, Drug & Biomarker Discovery Application, Disease Diagnostics Application and Cancer Diagnostics Application for the Years 2025 & 2030
- TABLE 64: China Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by End-Use - Academic & Research Institutions End-Use, Pharma & Biotech Companies End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 65: China 6-Year Perspective for Next-generation Sequencing Library Preparation by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutions End-Use, Pharma & Biotech Companies End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2025 & 2030
- TABLE 66: China Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Product Type - Library Preparation Reagents & Consumables and Library Preparation Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 67: China 6-Year Perspective for Next-generation Sequencing Library Preparation by Product Type - Percentage Breakdown of Value Sales for Library Preparation Reagents & Consumables and Library Preparation Instruments for the Years 2025 & 2030
EUROPE
- Next-generation Sequencing Library Preparation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
- TABLE 68: Europe Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 69: Europe 6-Year Perspective for Next-generation Sequencing Library Preparation by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
- TABLE 70: Europe Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Sequencing Type - Targeted Genome Sequencing, Whole Genome Sequencing, Whole Exome Sequencing and Other Sequencing Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 71: Europe 6-Year Perspective for Next-generation Sequencing Library Preparation by Sequencing Type - Percentage Breakdown of Value Sales for Targeted Genome Sequencing, Whole Genome Sequencing, Whole Exome Sequencing and Other Sequencing Types for the Years 2025 & 2030
- TABLE 72: Europe Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Application - Reproductive Health Diagnostics Application, Infectious Disease Diagnostics Application, Other Disease Diagnostic Applications, Drug & Biomarker Discovery Application, Disease Diagnostics Application and Cancer Diagnostics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 73: Europe 6-Year Perspective for Next-generation Sequencing Library Preparation by Application - Percentage Breakdown of Value Sales for Reproductive Health Diagnostics Application, Infectious Disease Diagnostics Application, Other Disease Diagnostic Applications, Drug & Biomarker Discovery Application, Disease Diagnostics Application and Cancer Diagnostics Application for the Years 2025 & 2030
- TABLE 74: Europe Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by End-Use - Academic & Research Institutions End-Use, Pharma & Biotech Companies End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 75: Europe 6-Year Perspective for Next-generation Sequencing Library Preparation by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutions End-Use, Pharma & Biotech Companies End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2025 & 2030
- TABLE 76: Europe Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Product Type - Library Preparation Reagents & Consumables and Library Preparation Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 77: Europe 6-Year Perspective for Next-generation Sequencing Library Preparation by Product Type - Percentage Breakdown of Value Sales for Library Preparation Reagents & Consumables and Library Preparation Instruments for the Years 2025 & 2030
FRANCE
- Next-generation Sequencing Library Preparation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
- TABLE 78: France Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Sequencing Type - Targeted Genome Sequencing, Whole Genome Sequencing, Whole Exome Sequencing and Other Sequencing Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 79: France 6-Year Perspective for Next-generation Sequencing Library Preparation by Sequencing Type - Percentage Breakdown of Value Sales for Targeted Genome Sequencing, Whole Genome Sequencing, Whole Exome Sequencing and Other Sequencing Types for the Years 2025 & 2030
- TABLE 80: France Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Application - Reproductive Health Diagnostics Application, Infectious Disease Diagnostics Application, Other Disease Diagnostic Applications, Drug & Biomarker Discovery Application, Disease Diagnostics Application and Cancer Diagnostics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 81: France 6-Year Perspective for Next-generation Sequencing Library Preparation by Application - Percentage Breakdown of Value Sales for Reproductive Health Diagnostics Application, Infectious Disease Diagnostics Application, Other Disease Diagnostic Applications, Drug & Biomarker Discovery Application, Disease Diagnostics Application and Cancer Diagnostics Application for the Years 2025 & 2030
- TABLE 82: France Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by End-Use - Academic & Research Institutions End-Use, Pharma & Biotech Companies End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 83: France 6-Year Perspective for Next-generation Sequencing Library Preparation by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutions End-Use, Pharma & Biotech Companies End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2025 & 2030
- TABLE 84: France Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Product Type - Library Preparation Reagents & Consumables and Library Preparation Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 85: France 6-Year Perspective for Next-generation Sequencing Library Preparation by Product Type - Percentage Breakdown of Value Sales for Library Preparation Reagents & Consumables and Library Preparation Instruments for the Years 2025 & 2030
GERMANY
- Next-generation Sequencing Library Preparation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
- TABLE 86: Germany Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Sequencing Type - Targeted Genome Sequencing, Whole Genome Sequencing, Whole Exome Sequencing and Other Sequencing Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 87: Germany 6-Year Perspective for Next-generation Sequencing Library Preparation by Sequencing Type - Percentage Breakdown of Value Sales for Targeted Genome Sequencing, Whole Genome Sequencing, Whole Exome Sequencing and Other Sequencing Types for the Years 2025 & 2030
- TABLE 88: Germany Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Application - Reproductive Health Diagnostics Application, Infectious Disease Diagnostics Application, Other Disease Diagnostic Applications, Drug & Biomarker Discovery Application, Disease Diagnostics Application and Cancer Diagnostics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 89: Germany 6-Year Perspective for Next-generation Sequencing Library Preparation by Application - Percentage Breakdown of Value Sales for Reproductive Health Diagnostics Application, Infectious Disease Diagnostics Application, Other Disease Diagnostic Applications, Drug & Biomarker Discovery Application, Disease Diagnostics Application and Cancer Diagnostics Application for the Years 2025 & 2030
- TABLE 90: Germany Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by End-Use - Academic & Research Institutions End-Use, Pharma & Biotech Companies End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 91: Germany 6-Year Perspective for Next-generation Sequencing Library Preparation by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutions End-Use, Pharma & Biotech Companies End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2025 & 2030
- TABLE 92: Germany Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Product Type - Library Preparation Reagents & Consumables and Library Preparation Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 93: Germany 6-Year Perspective for Next-generation Sequencing Library Preparation by Product Type - Percentage Breakdown of Value Sales for Library Preparation Reagents & Consumables and Library Preparation Instruments for the Years 2025 & 2030
ITALY
- TABLE 94: Italy Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Sequencing Type - Targeted Genome Sequencing, Whole Genome Sequencing, Whole Exome Sequencing and Other Sequencing Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 95: Italy 6-Year Perspective for Next-generation Sequencing Library Preparation by Sequencing Type - Percentage Breakdown of Value Sales for Targeted Genome Sequencing, Whole Genome Sequencing, Whole Exome Sequencing and Other Sequencing Types for the Years 2025 & 2030
- TABLE 96: Italy Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Application - Reproductive Health Diagnostics Application, Infectious Disease Diagnostics Application, Other Disease Diagnostic Applications, Drug & Biomarker Discovery Application, Disease Diagnostics Application and Cancer Diagnostics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 97: Italy 6-Year Perspective for Next-generation Sequencing Library Preparation by Application - Percentage Breakdown of Value Sales for Reproductive Health Diagnostics Application, Infectious Disease Diagnostics Application, Other Disease Diagnostic Applications, Drug & Biomarker Discovery Application, Disease Diagnostics Application and Cancer Diagnostics Application for the Years 2025 & 2030
- TABLE 98: Italy Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by End-Use - Academic & Research Institutions End-Use, Pharma & Biotech Companies End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 99: Italy 6-Year Perspective for Next-generation Sequencing Library Preparation by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutions End-Use, Pharma & Biotech Companies End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2025 & 2030
- TABLE 100: Italy Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Product Type - Library Preparation Reagents & Consumables and Library Preparation Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 101: Italy 6-Year Perspective for Next-generation Sequencing Library Preparation by Product Type - Percentage Breakdown of Value Sales for Library Preparation Reagents & Consumables and Library Preparation Instruments for the Years 2025 & 2030
UNITED KINGDOM
- Next-generation Sequencing Library Preparation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
- TABLE 102: UK Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Sequencing Type - Targeted Genome Sequencing, Whole Genome Sequencing, Whole Exome Sequencing and Other Sequencing Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 103: UK 6-Year Perspective for Next-generation Sequencing Library Preparation by Sequencing Type - Percentage Breakdown of Value Sales for Targeted Genome Sequencing, Whole Genome Sequencing, Whole Exome Sequencing and Other Sequencing Types for the Years 2025 & 2030
- TABLE 104: UK Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Application - Reproductive Health Diagnostics Application, Infectious Disease Diagnostics Application, Other Disease Diagnostic Applications, Drug & Biomarker Discovery Application, Disease Diagnostics Application and Cancer Diagnostics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 105: UK 6-Year Perspective for Next-generation Sequencing Library Preparation by Application - Percentage Breakdown of Value Sales for Reproductive Health Diagnostics Application, Infectious Disease Diagnostics Application, Other Disease Diagnostic Applications, Drug & Biomarker Discovery Application, Disease Diagnostics Application and Cancer Diagnostics Application for the Years 2025 & 2030
- TABLE 106: UK Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by End-Use - Academic & Research Institutions End-Use, Pharma & Biotech Companies End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 107: UK 6-Year Perspective for Next-generation Sequencing Library Preparation by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutions End-Use, Pharma & Biotech Companies End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2025 & 2030
- TABLE 108: UK Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Product Type - Library Preparation Reagents & Consumables and Library Preparation Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 109: UK 6-Year Perspective for Next-generation Sequencing Library Preparation by Product Type - Percentage Breakdown of Value Sales for Library Preparation Reagents & Consumables and Library Preparation Instruments for the Years 2025 & 2030
REST OF EUROPE
- TABLE 110: Rest of Europe Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Sequencing Type - Targeted Genome Sequencing, Whole Genome Sequencing, Whole Exome Sequencing and Other Sequencing Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 111: Rest of Europe 6-Year Perspective for Next-generation Sequencing Library Preparation by Sequencing Type - Percentage Breakdown of Value Sales for Targeted Genome Sequencing, Whole Genome Sequencing, Whole Exome Sequencing and Other Sequencing Types for the Years 2025 & 2030
- TABLE 112: Rest of Europe Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Application - Reproductive Health Diagnostics Application, Infectious Disease Diagnostics Application, Other Disease Diagnostic Applications, Drug & Biomarker Discovery Application, Disease Diagnostics Application and Cancer Diagnostics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 113: Rest of Europe 6-Year Perspective for Next-generation Sequencing Library Preparation by Application - Percentage Breakdown of Value Sales for Reproductive Health Diagnostics Application, Infectious Disease Diagnostics Application, Other Disease Diagnostic Applications, Drug & Biomarker Discovery Application, Disease Diagnostics Application and Cancer Diagnostics Application for the Years 2025 & 2030
- TABLE 114: Rest of Europe Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by End-Use - Academic & Research Institutions End-Use, Pharma & Biotech Companies End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 115: Rest of Europe 6-Year Perspective for Next-generation Sequencing Library Preparation by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutions End-Use, Pharma & Biotech Companies End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2025 & 2030
- TABLE 116: Rest of Europe Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Product Type - Library Preparation Reagents & Consumables and Library Preparation Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 117: Rest of Europe 6-Year Perspective for Next-generation Sequencing Library Preparation by Product Type - Percentage Breakdown of Value Sales for Library Preparation Reagents & Consumables and Library Preparation Instruments for the Years 2025 & 2030
ASIA-PACIFIC
- Next-generation Sequencing Library Preparation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
- TABLE 118: Asia-Pacific Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Sequencing Type - Targeted Genome Sequencing, Whole Genome Sequencing, Whole Exome Sequencing and Other Sequencing Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 119: Asia-Pacific 6-Year Perspective for Next-generation Sequencing Library Preparation by Sequencing Type - Percentage Breakdown of Value Sales for Targeted Genome Sequencing, Whole Genome Sequencing, Whole Exome Sequencing and Other Sequencing Types for the Years 2025 & 2030
- TABLE 120: Asia-Pacific Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Application - Reproductive Health Diagnostics Application, Infectious Disease Diagnostics Application, Other Disease Diagnostic Applications, Drug & Biomarker Discovery Application, Disease Diagnostics Application and Cancer Diagnostics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 121: Asia-Pacific 6-Year Perspective for Next-generation Sequencing Library Preparation by Application - Percentage Breakdown of Value Sales for Reproductive Health Diagnostics Application, Infectious Disease Diagnostics Application, Other Disease Diagnostic Applications, Drug & Biomarker Discovery Application, Disease Diagnostics Application and Cancer Diagnostics Application for the Years 2025 & 2030
- TABLE 122: Asia-Pacific Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by End-Use - Academic & Research Institutions End-Use, Pharma & Biotech Companies End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 123: Asia-Pacific 6-Year Perspective for Next-generation Sequencing Library Preparation by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutions End-Use, Pharma & Biotech Companies End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2025 & 2030
- TABLE 124: Asia-Pacific Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Product Type - Library Preparation Reagents & Consumables and Library Preparation Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 125: Asia-Pacific 6-Year Perspective for Next-generation Sequencing Library Preparation by Product Type - Percentage Breakdown of Value Sales for Library Preparation Reagents & Consumables and Library Preparation Instruments for the Years 2025 & 2030
REST OF WORLD
- TABLE 126: Rest of World Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Sequencing Type - Targeted Genome Sequencing, Whole Genome Sequencing, Whole Exome Sequencing and Other Sequencing Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 127: Rest of World 6-Year Perspective for Next-generation Sequencing Library Preparation by Sequencing Type - Percentage Breakdown of Value Sales for Targeted Genome Sequencing, Whole Genome Sequencing, Whole Exome Sequencing and Other Sequencing Types for the Years 2025 & 2030
- TABLE 128: Rest of World Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Application - Reproductive Health Diagnostics Application, Infectious Disease Diagnostics Application, Other Disease Diagnostic Applications, Drug & Biomarker Discovery Application, Disease Diagnostics Application and Cancer Diagnostics Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 129: Rest of World 6-Year Perspective for Next-generation Sequencing Library Preparation by Application - Percentage Breakdown of Value Sales for Reproductive Health Diagnostics Application, Infectious Disease Diagnostics Application, Other Disease Diagnostic Applications, Drug & Biomarker Discovery Application, Disease Diagnostics Application and Cancer Diagnostics Application for the Years 2025 & 2030
- TABLE 130: Rest of World Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by End-Use - Academic & Research Institutions End-Use, Pharma & Biotech Companies End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 131: Rest of World 6-Year Perspective for Next-generation Sequencing Library Preparation by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutions End-Use, Pharma & Biotech Companies End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2025 & 2030
- TABLE 132: Rest of World Recent Past, Current & Future Analysis for Next-generation Sequencing Library Preparation by Product Type - Library Preparation Reagents & Consumables and Library Preparation Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 133: Rest of World 6-Year Perspective for Next-generation Sequencing Library Preparation by Product Type - Percentage Breakdown of Value Sales for Library Preparation Reagents & Consumables and Library Preparation Instruments for the Years 2025 & 2030